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Abstract
Background: Low levels of high density lipoprotein (HDL) cholesterol and disturbed postprandial
lipemia are associated with coronary heart disease. In the present study, we evaluated the variation
of triglyceride (TG) postprandially in respect to serum HDL cholesterol levels.
Results: Fifty two Greek men were divided into 2 main groups: a) the low HDL group (HDL < 40
mg/dl), and b) the control group. Both groups were further matched according to fasting TG
(matched-low HDL, and matched-control groups). The fasting TG concentrations were higher in
the low HDL group compared to controls (p = 0.002). The low HDL group had significantly higher
TG at 4, 6 and 8 h postprandially compared to the controls (p = 0.006, p = 0.002, and p < 0.001,
respectively). The matched-low HDL group revealed higher TG only at 8 h postprandially (p =
0.017) compared to the matched-control group. ROC analysis showed that fasting TG ≥ 121 mg/
dl have 100% sensitivity and 81% specificity for an abnormal TG response (auc = 0.962, p < 0.001).
Conclusions: The delayed TG clearance postprandially seems to result in low HDL cholesterol
even in subjects with low fasting TG. The fasting TG > 121 mg/dl are predictable for abnormal
response to fatty meal.
Background
The hypothesis that low levels of high density lipoprotein
(HDL) cholesterol is associated with coronary heart dis-
ease (CHD), raised since the 1950s [1]. Fifty years later, it
was well-established [2,3] as it has been excellently
proved after a number of large prospective studies [4,5]. In
the PROCAM Study [6] 45% of men and women who
developed CHD had an HDL cholesterol lower than 35
mg/dl. In the Framingham Heart Study, total cholesterol
levels did not provide a predictive value in identifying
people at risk for CHD compared to cholesterol/HDL
ratio [7]. Furthermore, a change in ratio is better predictor
for successful CHD risk reduction than changes in total
cholesterol levels. There is no longer any doubt that HDL
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cholesterol is a powerful independent inverse predictor of
CHD. On the other hand, the long duration of the post-
prandial lipemia and repetition of meals during the day-
time leads to important changes of lipoproteins
postprandially. Studies have shown that disturbed post-
prandial lipemia is found in patients with CHD [8,9] and
other conditions [10-12] related to an increased risk of
cardiovascular disease. Many studies comparing patients
with CHD and controls have shown that postprandial
triglyceride (TG) levels were an independent predictor of
CHD in multivariate analysis [8,13]. In the present study,
we evaluated the variation of TG postprandially in respect
to serum HDL cholesterol levels. The delayed TG clear-
ance postprandially seems to result in low HDL choles-
terol even in subjects with low fasting TG.
Results
All participants ingested their fatty meal and tolerated it
well.
Baseline characteristics (Table 1)
The clinical characteristics of the two main study groups
(low HDL and controls) are shown in Table 1. Renal and
liver function was normal as determined by measuring
plasma creatinine, urea, uric acid, alanine aminotrans-
ferase, aspartate aminotransferase and γ-glutamate trans-
ferase. Therefore, there was no biochemical evidence of a
fatty liver. Baseline glucose levels were similar in both
groups. None of the patients fulfilled the criteria for the
metabolic syndrome according to the National Choles-
terol Education Program- Adults Treatment Panel III
(NCEP ATP III) guidelines [14].
The plasma HDL cholesterol and apolipoprotein A were
lower in low HDL group compared to controls (p < 0.001,
and p = 0.007, respectively) by definition. The fasting TG
(TG0) concentrations were higher in low HDL cholesterol
group compared to controls (p = 0.002).
Postprandial TG concentrations in the two main groups 
(low HDL subjects and controls) (Table 1, Figure 1)
TG levels 4 h after the fatty meal (TG4)
The low HDL subjects had a significantly higher (p  <
0.006) TG level compared to the controls.
TG levels 6 h after the fatty meal (TG6)
The low HDL subjects had a significantly higher (p  <
0.002) TG level compared to controls.
TG levels 8 h after the fatty meal (TG8)
The low HDL subjects had a significantly higher (p  <
0.001) TG level compared to the controls.
Glucose did not show any change postprandially.
The above groups were subdivided in matched-low HDL
and matched-control group (matched for low fasting TG
levels) and in low HDL-Abnormal (low HDL-A) and low
HDL-Normal (low HDL-N) groups (based on their TG
postprandial response).
Results of the matched low HDL subjects and matched 
controls (Table 2, Figure 1)
Subjects with low HDL cholesterol had higher TG concen-
tration at 8 h postprandially (p = 0.017).
Results of the low HDL subjects divided into those with 
(low HDL-N group) and without (low HDL-A group) a 
normal response to a fatty meal (Table 3, Figure 1)
Thirteen (45%) of the low HDL subjects (low HDL-A
group) had an abnormal TG response to the fatty meal test
compared to the controls. The other sixteen low HDL sub-
jects (low HDL-N group) had a TG response to the fatty
meal that was similar to that in the control subjects. The
low HDL subjects with an abnormal fatty meal response
(low HDL-A group) had higher plasma total cholesterol
and lower lipoprotein (a) concentrations (p = 0.007, and
p  < 0.012, respectively). As expected, postprandial TG
Table 1: Clinical characteristics of the two main study groups (all 
low HDL patients and controls). All biochemical values were 
obtained in the fasting state and for TG 4,6,8 h postprandially.
Characteristics Low HDL n = 29 Controls n = 23 P values
Age (years) 45(13) 51(9) NS
BMI (kg/m2) 26(2) 26(3) NS
CHD -/+ 19/10 23/0 0.002
Hypertension-/+ 27/2 23/0 NS
Smokers-/+ 17/12 23/0 <0.001
Diabetes mellitus 28/1 23/0 NS
TC (mg/dl) 198(45) 194(38) NS
HDL (mg/dl) 31(7) 53(19) <0.001
LDL (mg/dl) 141(39) 124(38) NS
Apo A (mg/dl) 123(28) 153(42) 0.007
Apo B (mg/dl) 127(56) 126(30) NS
Lp (a) (mg/dl) 25(25) 30(29) NS
Glucose (mg/dl) 94(13) 90(11) NS
TG0 (mg/dl) 128(54) 89(30) 0.002
TG4 (mg/dl) 207(102) 140(36) 0.006
TG6 (mg/dl) 210(112) 135(45) 0.002
TG8 (mg/dl) 192(92) 103(37) <0.001
AUC (mg/dl/h) 1459(631) 1007(253) <0.005
All values are presented as means (standard deviation). BMI: body 
mass index, CHD: coronary heart disease, TC: total cholesterol, 
HDL: high-density lipoprotein cholesterol, LDL: low-density 
lipoprotein cholesterol, Apo: apolipoprotein, Lp: lipoprotein, TG0: 
fasting plasma triglyceride concentration, TG4, TG6, TG8: plasma 
triglyceride concentration 4,6,8 h after the fat load, respectively, 
AUC: area under the curve. For TC, HDL and LDL, to convert from 
mg/dl to mmol/L divide by 38.7 For TG, to convert from mg/dl to 
mmol/L divide by 88.6Lipids in Health and Disease 2004, 3:18 http://www.lipidworld.com/content/3/1/18
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Schematic representation of TG-AUC of all groups in relation to time Figure 1
Schematic representation of TG-AUC of all groups in relation to time. The highest AUC values were observed in low HDL and 
low HDL-A groups which are characterized by low fasting HDL levels and the highest fasting TG levels compared to the other 
groups. The lowest AUC values were found in matched-low HDL, matched-controls, low HDL-N and control groups. These 
are characterized by lower fasting TG levels but with variable fasting HDL levels, ranging from 30(9) to 55(20) mg/dl. This 
means that the primary determinant of the magnitude of TG postprandial response is the fasting TG concentration. TG-AUC: 
triglyceride-area under the curve Low HDL-A: low HDL-Abnormal group Low HDL-N: low HDL-Normal group
Table 2: Clinical characteristics and biochemical parameters of the low HDL subjects matched to controls for fasting TG levels, and 
their response to a fatty meal.
Characteristics Matched-low HDL n = 20 Matched-controls n = 20 P values
Age (years) 47(13) 51(10) NS
BMI (kg/m2) 26(2) 25(2) NS
CHD -/+ 11/9 20/0 0.001
Hypertension-/+ 18/2 20/0 NS
Smokers-/+ 13/7 20/0 0.004
TC (mg/dl) 187(50) 197(35) NS
HDL (mg/dl 31(8) 55(20) <0.001
LDL (mg/dl) 136(43) 128(38) NS
Apo A (mg/dl) 123(31) 158(43) 0.009
Apo B (mg/dl) 123(63) 132(27) NS
Lp (a) (mg/dl) 29(27) 28(23) NS
Glucose (mg/dl) 95(14) 90(11) NS
TG0 (mg/dl) 100(31) 95(27) NS
TG4 (mg/dl) 153(55) 140(36) NS
TG6 (mg/dl) 172(105) 138(45) NS
TG8 (mg/dl) 154(78) 105(38) 0.017
AUC (mg/dl/h) 1142(322) 1007(253) NS
All values are presented as means (standard deviation). BMI: body mass index, CHD: coronary heart disease, TC: total cholesterol, HDL: high-
density lipoprotein cholesterol, LDL: low-density lipoprotein cholesterol, Apo: apolipoprotein, Lp: lipoprotein, TG0: fasting plasma triglyceride 
concentration, TG4, TG6, TG8: plasma triglyceride concentration 4,6,8 h after the fat load, respectively, AUC: area under the curve. For TC, HDL 
and LDL, to convert from mg/dl to mmol/L divide by 38.7 For TG, to convert from mg/dl to mmol/L divide by 88.6Lipids in Health and Disease 2004, 3:18 http://www.lipidworld.com/content/3/1/18
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levels were higher in those classified as having an abnor-
mal response.
TG levels of all groups (low HDL, controls, matched low
HDL, matched controls, low HDL-A, low HDL-N) in rela-
tion to time are schematically represented in Figure 1.
Predictors of abnormal TG response
In multivariate linear regression analysis, where the inde-
pendent variables were age, body mass index (BMI), total
cholesterol, HDL cholesterol, TG, lipoprotein (a), and
areas under the curve (AUC) was the dependent variable,
the TG0 was the only predictor of high AUC values (Coef-
ficience B = 7.15, p = 0.016). ROC analysis showed that
TG0 levels ≥ 121 mg/dl have 100% sensitivity and 81%
specificity for an abnormal TG response (auc=0.962, p <
0.001). After we divided the low HDL men in low- or
high- groups by using the ROC curve cut-off values of TG0,
total cholesterol and lipoprotein (a), i.e. low/high TG0,
low/high total cholesterol and low/high lipoprotein (a)
groups, the only distinction that predicted an abnormal
TG response was the high-TG0 group (p < 0.001)
Discussion
In the present study, we found that a slower clearance of
TG-rich lipoproteins from circulation postprandially
results in low fasting levels of HDL cholesterol. Addition-
ally, fasting plasma TG concentration is the primary deter-
minant of the magnitude of postprandial lipemia.
Subjects with a low fasting HDL and low TG levels showed
a delayed TG clearance at 8 h compared to those with a
normal fasting HDL value. The increase in TGs (from 2 to
4 h) after meal consumption mainly reflects dietary TG
absorption, whereas the return to fasting levels (from 6 to
9 h) is presumably a function of TG clearance [15]. In our
study, the delayed response of TGs to the fatty meal in
matched group for low fasting TG levels may be indicative
for an HDL involvement. It has been proposed that ele-
vated plasma TG concentrations promote the cholesterol
ester exchange reactions mediated by cholesteryl ester
transfer protein [16]. It is possible that in this transient
hypertriglyceridemia, the HDL particles are TG-enriched
via cholesteryl ester transfer protein mediated exchange
with TG-rich lipoproteins. Such HDL-TG enriched parti-
cles are cleared more rapidly from the circulation [17]
leading to low serum HDL cholesterol levels [18,19]. In
subjects with initially low HDL concentrations and low
fasting TG levels, it is possible that this reaction does not
happen at all or happens in a less degree and the slower
removal of TGs from the circulation could be explained by
insufficient amount of HDL particles which are responsi-
ble for their clearance.
The high TG and low HDL cholesterol phenotype has
been frequently reported in "abdominal" obesity [20,21].
Obesity is associated with a range of metabolic abnormal-
ities including fasting and postprandial dyslipidemia.
This was clearly shown in the study of Couillard et al.,
Table 3: Clinical characteristics and biochemical parameters of the low HDL subjects with an abnormal (low HDL-A) and normal 
response (low HDL-N) to a fatty meal.
Characteristics low HDL-A n = 13 low HDL-N n = 16 P values
Age (years) 42(14) 48(13) NS
BMI (kg/m2) 26(2) 27(3) NS
CHD-/+ 12/1 7/9 0.006
Hypertension-/+ 11/2 16/0 NS
Smokers-/+ 6/7 11/5 NS
TC (mg/dl) 221(16) 179(53) 0.007
HDL (mg/dl) 32(5) 30(9) NS
LDL (mg/dl) 154(22) 130(46) NS
Apo A (mg/dl) 131(18) 118(31) NS
Apo B (mg/dl) 135(17) 122(68) NS
Lp (a) (mg/dl) 10(7) 32(28) 0.012
Glucose (mg/dl) 92(11) 95(14) NS
TG0 (mg/dl) 172(43) 92(29) <0.001
TG4 (mg/dl) 298(82) 135(35) <0.001
TG6 (mg/dl) 321(74) 127(35) <0.001
TG8 (mg/dl) 270(78) 129(37) < 0.001
AUC (mg/dl/h) 2074(381) 986(252) <0.012
All values are presented as means (standard deviation) BMI: body mass index, CHD: coronary heart disease, TC: total cholesterol, HDL: high-
density lipoprotein cholesterol, LDL: low-density lipoprotein cholesterol, Apo: apolipoprotein, Lp: lipoprotein, TG0: fasting plasma triglyceride 
concentration, TG4, TG6, TG8: plasma triglyceride concentration 4,6,8 h after the fat load, respectively, AUC: area under the curve. For TC, HDL 
and LDL, to convert from mg/dl to mmol/L divide by 38.7 For TG, to convert from mg/dl to mmol/L divide by 88.6Lipids in Health and Disease 2004, 3:18 http://www.lipidworld.com/content/3/1/18
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whose study subjects were characterised by a BMI of 32.3
± 4.5 kg/m2 [22]. Our results showed that even in slightly
overweight subjects with a BMI of 26 ± 2 kg/m2, this phe-
notype may provoke similar metabolic abnormalities. The
HDL formation is closely associated with TG catabolism
[23] as mentioned above. The deleterious effect of the
high TG and low HDL phenotype on the rate of postpran-
dial TG clearance has been also shown in children (mean
age 14 years old) [24]. Patsch et al., [25] have proposed
that low HDL cholesterol levels could result from an
impaired TG lipolysis, a condition that would favour an
exaggerated postprandial lipemia, in subject with
hypoalphalipoproteinemia.
In our study, no difference was observed in the early post-
prandial TG response (absorption phase) between nor-
molipidemic controls and men with low fasting HDL
cholesterol and low fasting plasma TG concentration. In
contrast, the group with low HDL cholesterol (31 ± 7 mg/
dl) and variable values of fasting TG (53–248 mg/dl,
mean value 128 ± 54 mg/dl) revealed a higher TG curve
postprandially compared to healthy subjects with moder-
ate HDL cholesterol (53 ± 19 mg/dl) and low fasting TG
levels (89 ± 30 mg/dl). When both groups were matched
for fasting TG levels, this curve-difference was diminished,
although HDL cholesterol levels remained significantly
different between the two groups. When subjects with low
HDL cholesterol were subdivided based on their response
(normal or abnormal) to fat loading, fasting TG concen-
tration seemed to be the critical determinant of such
response. Since there are no official guidelines to deter-
mine normal postprandial TG ranges, the characterization
of a TG response as "normal" or "abnormal" after fat load-
ing was based on this report and on previous reports of
ours and others. The peak TG mean value in control sub-
jects was 139 ± 41 mg/dl (at 6 h) [11], 176 ± 17 mg/dl (at
3.5 h) [26], 177 mg/dl [27] and 186 mg/dl [28]. Higher
TG concentrations at 4 h were reported by others, approx-
imately 213 mg/dl and 248 mg/dl [29-32]. Therefore, we
defined an abnormal postprandial TG response to the
fatty meal as any postprandial TG concentration (at 4, 6 or
8 h) higher than 219 mg/dl which was the highest TG con-
centration in any hour in any control individual. Subjects
with abnormal postprandial lipemia had fasting TG con-
centration twice higher than those with normal postpran-
dial lipemia and the TG concentration remained much
higher through all tests. Additionally, the ROC analysis
showed that TG0 level ≥ 121 mg/dl have 100% sensitivity
and 81% specificity for an abnormal TG response.
Couillard et al., [22] reported a significant association
between the magnitude of the postprandial TG response
and fasting plasma HDL cholesterol concentrations. How-
ever, the subjects included in their study showed a wider
range of fasting TG concentrations (44–390 mg/dl) com-
pared to ours (53–248 mg/dl). In the subgroup of isolated
low fasting HDL cholesterol, fasting hypertriglyceridemia
was a prerequisite in order to have an exaggerated
postprandial TG response [22]. This finding was similar to
ours; an abnormal response to the fatty meal was only
dependent on fasting TG concentration. Cohen and co-
workers [33] measured plasma TG and retinyl palmitate
responses to different fat meals in endurance-trained men
with a wide range of plasma HDL cholesterol concentra-
tions (36–105 mg/dl). Their data indicated that the mag-
nitude of postprandial lipemia is not primarily affected by
the HDL cholesterol concentrations, which agrees to our
results. However, they failed to show any correlation
between HDL cholesterol levels and chylomicron rem-
nant metabolism which is contradictory to our findings,
although we did not directly measured chylomicron rem-
nant particles.
Postprandial hypertriglyceridemia is not a uniform abnor-
mality. It pathophysiologic cause is not yet known. It is
possible that the response to a fatty meal is gene depend-
ent. It has been reported that a number of gene loci, such
as these of apolipoprotein E, lipoprotein lipase, apolipo-
protein CIII, apolipoprotein A1, apolipoprotein A4, cho-
lesterol ester transfer protein are related to fat load
response [34,35]. However, this gene polymorphism-
dependence remains controversial, and it is more likely
that the postprandial lipemia is a polygenic phenomenon,
although the phenotype of the postprandial lipemia is
probably one. This concept allowed us to study only the
phenotypic manifestation of the postprandial lipemia,
which would have immediate clinical implications. Our
aim was to evaluate the postprandial response in men
with isolated low fasting HDL cholesterol. Although it has
been also described elsewhere that baseline TG levels
impact on the postprandial response and that HDL cho-
lesterol levels are predictors of this response, the novelty
of this study lies on the fact that delayed postprandially
TG clearance was observed in low HDL group and that
emphasis should be given on the decrease of TG levels <
121 mg/dl, lower that those indicated by the NCEP ATP III
guidelines.
Conclusions
The delayed TG clearance postprandially seems to result
in low HDL cholesterol levels even in subjects with low
fasting TG concentration. Moreover, fasting plasma TG
levels appear to be the primary determinant of the magni-
tude of postprandial lipemia. The fasting TG levels higher
than 121 mg/dl are predictable for abnormal response to
a fatty meal. This should be taken into account for the
management of patients with fasting low HDL cholesterol
levels.Lipids in Health and Disease 2004, 3:18 http://www.lipidworld.com/content/3/1/18
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Methods
Subjects
The study population consisted of 52 Greek men recruited
from the Lipid Clinic of Onassis Cardiac Surgery Center,
Athens, Greece. Heavy drinking, liver and renal disease,
diabetes mellitus, metabolic syndrome, according to the
NCEP ATP III guidelines [14], hypothyroidism and pro-
fessional sport activity were exclusion criteria. No subject
took lipid lowering drugs before entering the study. Only
patients with CHD (defined by angiography) were taking
soluble aspirin (100 mg) and isosorbide mononitrate (40
mg). No other patient or control subject was on
medication.
The study population was divided into 2 main categories:
A: The low HDL group and the control group.
1. The low HDL group consisted of 29 men, mean age
45(13) years with low HDL cholesterol (< 40 mg/dl)
according to NCEP ATP III guidelines [14].
2. The control group consisted of 23 healthy men, mean
age 51(9) years with no family history of premature
atherosclerosis, diabetes mellitus, arterial hypertension or
dyslipidemia. Their fasting TG levels were < 150 mg/dl,
total cholesterol < 240 mg/dl and HDL cholesterol = 40
mg/dl. All subjects were never smokers.
B: Matched groups according to fasting TG level.
1. The matched-low HDL group consisted of 20 men,
mean age 47(13) years with low HDL cholesterol and low
fasting TG levels [100(31) mg/dl].
2. The matched controls consisted of 20 men, mean age
51(10) years with lasting TG levels 95(27) mg/dl.
Fat-rich meal protocol and blood sample
All patients were studied in the outpatient clinic between
8.00–9.00 am after 12 hours (h) overnight fast. The fatty
meal was consumed within 20 min and plasma TG con-
centrations were measured before and 4, 6 and 8 h after
the fat load. During this 8 h period, the participants did
not eat; they could only drink water and they did not
smoke. Blood samples were drawn at 8:00 am (before the
meal), at 12:30 pm (4 h after the meal), at 2:30 pm (6 h
after the meal), and at 4:30 pm (8 h after the meal). In all
samples total cholesterol, TG, HDL, apolipoprotein A and
B, and lipoprotein (a) were measured. BMI was calculated
as weight divided by height (expressed in kg/m2).
Fatty meal
The fatty meal has been previously described [11]. Briefly,
the fatty meal was a slight modification of that described
by Patsch et al [8], consisting of 83.5% fat, 14.0 % carbo-
hydrates and 2.5 % proteins. This was administered in a
dose based on the patient's body surface area (350 g to 2
m2).
Definition of abnormal postprandial response
We defined postprandial hypertri-glyceridemia as any
postprandial TG concentration (at 4, 6 or 8 h) higher than
the highest TG concentration in any hour in any control
individual; this TG value was 219 mg/dl.
Determination of blood lipids and glucose
Plasma total cholesterol, TG and HDL cholesterol were
measured using enzymatic colorimetric methods on a
Roche Integra Biochemical analyzer with commercially
available kits (Roche). The serum low-density lipoprotein
cholesterol levels were calculated using the Friedewald
formula [36]. Apolipoprotein A, B and Lipoprotein (a)
were measured by nephelometery (Nephelometer:BN-
100, Behring, Germany). Blood glucose was measured by
the hexokinase method with a Dade Behring reagent on a
Dimension (Dade Behring) instrument. All samples were
analyzed within 24 h.
All participants gave their informed consent before the
study. The ethical committee of the Onassis Cardiac Sur-
gery Center approved the study.
Statistical analysis
Values of numerical characteristics were tested for normal-
ity and are presented as mean value with one standard
deviation, when normally distributed, or as median and
range, when they deviated from normality. A t-test for
independent samples or a Mann Whitney U test was used
for the comparison of numerical values between two
groups and ANOVA or Kruskal-Wallis test for three
groups, with Bonferoni correction for post hoc analysis.
The comparison of clinical categorical variables was per-
formed with the use of chi-square test. Multivariate linear
regression analysis was performed to determine the pre-
dictors of elevated AUC levels, where age, BMI, total cho-
lesterol, HDL cholesterol, fasting TG (TG0), and
lipoprotein (a) were the independent variables tested.
ROC curve statistics was used to estimate the cutoff value
of baseline triglyceride, cholesterol and lipoprotein (a)
levels (which they were significant univariate predictors of
elevated TG levels postprandially) above which the low
HDL men develop an abnormal TG response to fat load.
Using those cut-off values, we created dichotomous varia-
bles for each one of the univariate predictors to test their
significance in discriminating patients with abnormal TG
response to fat load. The level of significance was set at p
< 0.05. AUC for serial measurements of TG levels at base-
line and after the fatty meal were calculated using the trap-
ezoid rule.Lipids in Health and Disease 2004, 3:18 http://www.lipidworld.com/content/3/1/18
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